The Chinese diagnostic imaging system market will experience moderate growth over the forecast period as health care reform efforts bolster hospital spending in all tiers of the health care system. The market is further supported by an ongoing effort to digitize hospitals, which will support the adoption of highly integrated diagnostic imaging systems.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for diagnostic imaging systems in China across a 10-year period.
Chinese government is investing in digitization of its healthcare system and incorporating artificial intelligence in different aspects of diagnostic imaging systems market.
How has increased health care digitization impacted the market?
Which diagnostic imaging system segments will directly benefit from this increased investment?
How will this impact the strategies for domestic and foreign companies in this market?
How can manufacturers play an active role in health care reform?
The Chinese government has enacted a number of measures that promote the adoption of Chinese diagnostic imaging systems in all tiers of the health care system.
How can foreign companies remain competitive in this landscape?
What are the specific policies that the government has outlined to increase the adoption of domestic systems?
What are some of the challenges these policies will face given the current perception of domestic systems compared to foreign systems?
The Chinese government is improving regulations on import of diagnostic imaging systems and their distribution.
How will foreign companies benefit from this?
How will this impact the adoption of domestic imaging systems?
Table of contents
- China
- Abstract
- Executive Summary
- Market Highlights
- Competitive Highlights
- Market Developments
- Geographies Covered
- Products Covered
- Key Report Updates
- Diagnostic Imaging System Market
- Market Highlights
- Market Definitions
- General Regional Trends
- Market Forecast Data
- Competitive Highlights
- Market Shares
- Competitive Factors and Strategies
- Domestic Competitors
- Physician Training and Marketing
- Product Improvements and Innovations
- Product Portfolio Management
- Pricing Strategies and Purchasing Options
- Market Developments
- Magnetic Resonance Imaging System Market
- Market Highlights
- Market Definitions
- Market Forecast Data
- Competitive Highlights
- Market Shares
- Competitive Factors and Strategies
- Computed Tomography System Market
- Market Highlights
- Market Definitions
- Market Forecast Data
- Competitive Highlights
- Market Shares
- Competitive Factors and Strategies
- General Radiography System Market
- Market Highlights
- Market Definitions
- Market Forecast Data
- Competitive Highlights
- Market Shares
- Competitive Factors and Strategies
- Domestic Competitors
- Product Portfolio Management
- Ultrasound System Market
- Market Highlights
- Market Definitions
- Market Forecast Data
- Competitive Highlights
- Market Shares
- Competitive Factors and Strategies
- Domestic Competitors
- Nuclear Medicine System Market
- Market Highlights
- Market Definitions
- Market Forecast Data
- Competitive Highlights
- Market Shares
- Competitive Factors and Strategies
- Appendix
- Abbreviations
- Bibliography
Author(s): Hebri Nandita Mallya
Hebri Nandita Mallya is a research associate within the Endoscopy, Diagnostics, and Healthcare IT Medtech Insights team at DRG (Part of Clarivate), specializing in Diagnostic Imaging Systems market. Hebri Nandita Mallya holds a Bachelor's degree in Biotechnology, Chemistry and Zoology from Christ University, Bangalore, and a Master's degree in Medical Biochemistry from Manipal Academy of Higher Education.